Impact of Nodular Calcifications in the Aortic Annulus and Left Ventricular Outflow Tract on TAVI Outcome with New-Generation Devices.
computational simulation
device success
nodular calcification
paravalvular leak
transcatheter aortic valve implantation
Journal
Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
01
05
2022
revised:
10
07
2022
accepted:
31
07
2022
medline:
25
10
2022
pubmed:
25
10
2022
entrez:
30
7
2024
Statut:
epublish
Résumé
The impact of nodular calcifications in left ventricular outlow tract (LVOT) and aortic annulus on the procedural outcome of transcatheter aortic valve implantation (TAVI) with new-generation devices is yet to be elucidated. Similarly, computational simulations may provide a novel insight into the biomechanical features of TAVI devices and their interaction with nodular calcifications. This retrospective single-center study included 232 patients submitted to TAVI with Evolut-R (53.4%), Portico (33.6%) and Lotus (13.0%) devices with available preoperative computed tomography (CT) angiography and evidence of nodular calcifications in aortic annulus and/or LVOT. Calcification severity was defined At least moderate calcifications were found in 123 (53.0%) patients, with no sex differences. Among the At least moderate nodular calcifications in the annulus/LVOT region significantly affected TAVI outcome, as they were independent predictors of device success. Lotus and Portico seemed to perform better than Evolut-R as for device success and
Sections du résumé
Background
UNASSIGNED
The impact of nodular calcifications in left ventricular outlow tract (LVOT) and aortic annulus on the procedural outcome of transcatheter aortic valve implantation (TAVI) with new-generation devices is yet to be elucidated. Similarly, computational simulations may provide a novel insight into the biomechanical features of TAVI devices and their interaction with nodular calcifications.
Methods
UNASSIGNED
This retrospective single-center study included 232 patients submitted to TAVI with Evolut-R (53.4%), Portico (33.6%) and Lotus (13.0%) devices with available preoperative computed tomography (CT) angiography and evidence of nodular calcifications in aortic annulus and/or LVOT. Calcification severity was defined
Results
UNASSIGNED
At least moderate calcifications were found in 123 (53.0%) patients, with no sex differences. Among the
Conclusions
UNASSIGNED
At least moderate nodular calcifications in the annulus/LVOT region significantly affected TAVI outcome, as they were independent predictors of device success. Lotus and Portico seemed to perform better than Evolut-R as for device success and
Identifiants
pubmed: 39076178
doi: 10.31083/j.rcm2311358
pii: S1530-6550(22)00652-4
pmc: PMC11269076
doi:
Types de publication
Journal Article
Langues
eng
Pagination
358Informations de copyright
Copyright: © 2022 The Author(s). Published by IMR Press.
Déclaration de conflit d'intérêts
Francesco Bedogni is consultant for Medtronic, Abbott, and Boston Scientific; Nedy Brambilla and Luca Testa are consultants for Abbott and Boston Scientific. The other authors declare no conflict of interest.